INTERNATIONAL PATENT: HUMANWELL PHARMACEUTICAL US, INC. FILES APPLICATION FOR "BRIDGED TRICYCLIC GABA DERIVATIVES AS CALCIUM CHANNEL MODULATORS, METHODS OF MAKING AND METHODS OF USING THEREOF"

GENEVA, Jan. 6 -- HUMANWELL PHARMACEUTICAL US, INC. (421 Sovereign CourtBallwin, Missouri 63011) filed a patent application (PCT/US2025/035051) for "BRIDGED TRICYCLIC GABA DERIVATIVES AS CALCIUM CHANNEL MODULATORS, METHODS OF MAKING, AND METHODS OF USING THEREOF" on Jun 24, 2025. With publication no. WO/2026/006315, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): REDDY, Hariprasada Reddy Kanna (c/o HUMANWELL PHARMACEUTICAL US421 Sovereign CourtBallwin, Missouri 63011), KAUSHIK, Shivansh (c/o HUMANWELL PHARMACEUTICAL US421...